Forster Eliot insider trades
Forster Eliot has filed 8 Form 4s with the SEC that we hold, for FSTX (PRESIDENT AND CEO, Director), Protalix BioTherapeutics, Inc. (PLX) (Director) and Immatics N.V. (IMTX) (Director). None of these filings reports a purchase (code P) or sale (code S) of common stock; they cover grants, option exercises and other codes. The first filing on our record is dated 2022-01-11 and the latest 2026-09-04.
FSTX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Protalix BioTherapeutics, Inc. (PLX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Immatics N.V. (IMTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1831558) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms